WHO ICTRP trial
A post-marketing clinical study of Xiaoer Chaiqin Qingjie Granule for acute…
ChiCTR-IPR-17011035 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-IPR-17011035 |
|---|---|
| Public title | A post-marketing clinical study of Xiaoer Chaiqin Qingjie Granule for acute upper respiratory infection in children |
| Scientific title | A random, double-blind and imitation, positive-drug parallel-control, multi-center clinical study to evaluate efficacy and safety of Xiaoer Chaiqin Qingjie Granule for acute upper respiratory infection( heat in both superficies and interior) in children |
| Primary sponsor | Dongzhimen Hospital Beijing University of Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Countries | China |
| Conditions | Acute upper respiratory infection( heat in both superficies and interior) in children |
| Interventions | Treatment Group:Xiao'er Chai Qin Granule +Xiao'er Shuangqing Granule Placebo;Control Group:Xiao'er Shuangqing Granule+ Xiao'er Chai Qin Qingjie Granule Placebo |
| Registration date | Mar 31, 2017 |
| Target size | Treatment Group:120;Control Group:120 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: